Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$373.33 USD

373.33
1,136,838

+7.18 (1.96%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $373.22 -0.11 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (58 out of 246)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

David Borun headshot

More Record Highs in a Broadly Positive Week for US Equities

by David Borun

Easing of trade concerns and a steepening yield curve supporting steady share appreciation

Zacks Equity Research

HCA (HCA) is an Incredible Growth Stock: 3 Reasons Why

by Zacks Equity Research

HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Can Segmental Growth Aid Hologic (HOLX) in Q4 Earnings?

by Zacks Equity Research

Developments in Breast Health and Molecular Diagnostics businesses are likely to have aided Hologic's (HOLX) performance in fourth-quarter fiscal 2019.

Zacks Equity Research

HCA Healthcare (HCA) Catches Eye: Stock Jumps 6.4%

by Zacks Equity Research

HCA Healthcare (HCA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Zacks Equity Research

HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Improve Y/Y

by Zacks Equity Research

HCA Healthcare's (HCA) third-quarter results gain traction from better revenues.

Zacks Equity Research

HCA Holdings (HCA) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

HCA (HCA) delivered earnings and revenue surprises of 4.21% and 1.55%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Healthcare Stock Earnings Slated on Oct 29: HCA, MOH & More

by Zacks Equity Research

Increasing demands for products and services are likely to have driven earnings for players in the healthcare industry.

Zacks Equity Research

HCA Healthcare (HCA) to Post Q3 Earnings: What to Expect

by Zacks Equity Research

HCA Healthcare's (HCA) third-quarter results are likely to reflect elevated expenses, partly offset by higher topline from increase in admissions and licensed beds.

Sumit Singh headshot

Add These 5 Stocks With Amazing Interest Coverage Ratio

by Sumit Singh

Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.

Zacks Equity Research

Humana to Provide Florida's Retirees With Medicare Plans

by Zacks Equity Research

Humana's (HUM) Medicare plans to help the State of Florida Medicare-eligible retirees and their eligible dependents achieve better health outcomes.

Zacks Equity Research

MEDNAX (MD) to Sell MedData for Focusing on Core Business

by Zacks Equity Research

MEDNAX (MD) to divest its billing services business for streamlining its operations.

Zacks Equity Research

Will UnitedHealth's (UNH) Benefits Business Aid Q3 Earnings?

by Zacks Equity Research

Strength in UnitedHealth's (UNH) health service segment is likely to reflect in Q3 results.

Zacks Equity Research

Humana's New Plans to Complement VA Healthcare Coverage

by Zacks Equity Research

Humana's (HUM) Humana Honor Medicare Advantage plans to help veterans get better health outcomes. It will also complement the VA plan.

Zacks Equity Research

Centene's Carolina Complete Health Wins Medicaid Contract

by Zacks Equity Research

Centene's (CNC) provider-led North Carolina subsidiary clinches Medicaid contract to provide services in additional areas.

Zacks Equity Research

Humana's (HUM) Medicare Business Aids, High Costs Persist

by Zacks Equity Research

Humana's (HUM) revenues and membership gain on strong Medicare business. However, high expenses hurt.

Zacks Equity Research

Tenet Healthcare's Strategic Initiatives Aid, Revenues Drag

by Zacks Equity Research

Strategic divestitures bode well for Tenet Healthcare's (THC) growth. However, depleting revenues is a lingering woe.

Zacks Equity Research

Universal Health (UHS) Up 27.6% YTD: Will the Rally Continue?

by Zacks Equity Research

Universal Health (UHS) is poised to grow over the long term on the back of strong contribution from its segments and accretive acquisitions.

Sapna Bagaria headshot

Hospital Industry Outlook: Rising Baby Boomers to Drive Growth

by Sapna Bagaria

The Zacks Medical-Hospital industry is set to gain from demographic changes and growing consolidation amid high labor cost.

Zacks Equity Research

5 Factors That Make Acadia Healthcare Stock Look Unattractive

by Zacks Equity Research

Rising expenses, underperforming U.K business and low guidance are a drag on Acadia Healthcare's (ACHC) stock.

Zacks Equity Research

Here's Why You Should Avoid Acadia Healthcare Stock Now

by Zacks Equity Research

Lack of clarity on the sale of its underperforming U.K. business continues to hurt Acadia Healthcare (ACHC).

Zacks Equity Research

HCA (HCA) Down 10.8% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Can Value Investors Consider HCA Healthcare (HCA) Stock?

by Zacks Equity Research

HCA Healthcare (HCA) stock may be a good choice for value-oriented investors right now from multiple angles.

David Borun headshot

Trade and Currency Concerns Put Pressure on Equities

by David Borun

A busy week of data and a Fed meeting was dominated by China trade issues

Zacks Equity Research

Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (HCA) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

HCA Healthcare (HCA) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

HCA Healthcare's (HCA) second-quarter earnings decline due to escalating expenses.